Author:
Xie Wenwen,Song Yinyin,Qin Xiaomei,Jin Pengfei
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference39 articles.
1. Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(25):2889–934.
2. The Writing Committee of the Report on Cardiovascular Health and Diseases in China. Interpretation of report on cardiovascular health and diseases in China 2020. Chin J Cardiovasc Med. 2021;26(3):209–218.
3. Committee of Experts on Rational Drug Use of National Health Commission of the P.R. China, Chinese Pharmacists Association Guidelines for rational drug use for coronary heart disease (second edition) Chin J Front Med (electron Ed). 2018;10(06):1–130.
4. Zhang X, Jing L, Wang M, et al. Twenty-year epidemiologic study on LDL cholesterol levels in relation to the risks of atherosclerotic event, hemorrhagic stroke, and cancer death among young and middle-aged population in China. J Clin Lipidol. 2018;12(5):1179-89.e4.
5. Cholesterol treatment trialists collaboration (CTTC), Baigent C, Blackwell L, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet. 2010;376(9753):1670–81.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献